Role of TNF-α in Pulmonary Host Defense in Murine Invasive Aspergillosis
Open Access
- 1 February 1999
- journal article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 162 (3) , 1633-1640
- https://doi.org/10.4049/jimmunol.162.3.1633
Abstract
Invasive pulmonary aspergillosis is a common and devastating complication of immunosuppression, whose incidence has increased dramatically in tandem with the increase in the number of immunocompromised patients. Given the role of TNF-α in other pulmonary infections, we hypothesized that TNF-α is an important proximal signal in murine invasive pulmonary aspergillosis. Intratracheal challenge with Aspergillus fumigatus conidia in both neutropenic (cyclophosphamide-treated) and nonneutropenic BALB/c mice resulted in the time-dependent increase in lung TNF-α levels, which correlated with the histologic development of a patchy, peribronchial infiltration of mononuclear and polymorphonuclear cells. Ab-mediated neutralization of TNF-α resulted in an increase in mortality in both normal and cyclophosphamide-treated animals, which was associated with increased lung fungal burden as determined by histology and as quantified by chitin content. Depletion of TNF-α resulted in a reduced lung neutrophil influx in both normal and cyclophosphamide-treated animals, which occurred in association with a decrease in lung levels of the C-X-C chemokine, macrophage inflammatory protein-2 and the C-C chemokines macrophage inflammatory protein-1α and JE. In cyclophosphamide-treated animals, intratracheal administration of a TNF-α agonist peptide (TNF70–80) 3 days before, but not concomitant with, the administration of Aspergillus conidia resulted in improved survival from 9% in control mice to 55% in TNF70–80-treated animals. These studies indicate that TNF-α is a critical component of innate immunity in both immunocompromised and immunocompetent hosts, and that pretreatment with a TNF-α agonist peptide in a compartmentalized fashion can significantly enhance resistance to A. fumigatus in neutropenic animals.Keywords
This publication has 27 references indexed in Scilit:
- In VitroInteraction of Alveolar Macrophages andAspergillus FumigatusEnvironmental Research, 1997
- Therapeutic Outcome in Invasive AspergillosisClinical Infectious Diseases, 1996
- Trends in the postmortem epidemiology of invasive fungal infections at a University HospitalJournal of Infection, 1996
- Interferon- and Tumor Necrosis Factor- Protect Mice from Invasive AspergillosisThe Journal of Infectious Diseases, 1995
- A synthetic tumor necrosis factor-alpha agonist peptide enhances human polymorphonuclear leukocyte-mediated killing of Plasmodium falciparum in vitro and suppresses Plasmodium chabaudi infection in mice.Journal of Clinical Investigation, 1995
- Prophylactic efficacy of aerosolized liposomal (AmBisome) and non-lipsomal (Fungizone) amphotericin B in murine pulmonary aspergillosisJournal of Antimicrobial Chemotherapy, 1994
- Antifungal Activity Of Elutriated Human Monocytes Against Aspergillus Fumigatus Hyphae: Enhancement By Granulocyte-Macrophage Colonystimulating Factor And Interferon-aThe Journal of Infectious Diseases, 1994
- Phagocyte function and cytokine production in community acquired pneumonia.Thorax, 1994
- In Vitro Killing of Spores and Hyphae of Aspergillus fumigatus and Rhizopus oryzae by Rabbit Neutrophil Cationic Peptides and Bronchoalveolar MacrophagesThe Journal of Infectious Diseases, 1986
- In Vivo Bronchoalveolar Macrophage Defense Against Rhizopus oryzae and Aspergillus fumigatusThe Journal of Infectious Diseases, 1984